TruAlt Bioenergy Share Price Target 2026 Analyst Forecast Bull and Bear Case
- June 26, 2026
- Posted by: Neeraj Pandey
- Category: News
The TruAlt Bioenergy share price target 2026 is Rs 560, implying approximately 20 percent upside from the current market price of Rs 466.45 (NSE: TRUALT). With Q4 FY26 results released in 2026 and Biofuel and Ethanol Production tailwinds in focus, the Rs 560 price objective is supported by the FY27 earnings recovery thesis.
TruAlt Bioenergy (NSE: TRUALT) is a Biofuel and Ethanol Production company trading at Rs 466.45 with a market capitalisation of Rs 4,081 crore. Analysts have set the TruAlt Bioenergy share price target at Rs 560 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.
Click Here – Get Free Investment Predictions
TruAlt Bioenergy Share Price Target 2026: Key Takeaways
- TruAlt Bioenergy share price target 2026: Rs 560 (20% upside from CMP Rs 466.45)
- Bull case: Rs 675 | Bear case: Rs 375
- Ticker: TRUALT | Sector: Biofuel and Ethanol Production | MCap: Rs 4,081 crore
- 52W range: Rs 310.2 to Rs 542 | PE: 20x
- Key catalyst: Q4 FY26 results and FY27 earnings confirmation in 2026
- Key risk: FY27 earnings miss or FII outflows from Indian equities
TruAlt Bioenergy Company Overview
TruAlt Bioenergy (NSE: TRUALT) is a bioenergy company producing compressed biogas, ethanol, and biofuel blends from agricultural raw materials under the government’s ethanol blending and CBG programmes. At CMP Rs 466.45 against a 52 week range of Rs 310.2 to Rs 542, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 4,081 crore with trailing PE of 20x. Compared to peers in bioenergy like Praj Industries and ISGEC Heavy Engineering, TruAlt Bioenergy is positioned as a potential re-rating candidate toward the Rs 560 price objective on FY27 earnings delivery.
| Parameter | Value |
|---|---|
| NSE Ticker | TRUALT |
| Sector | Biofuel and Ethanol Production |
| CMP (2026) | Rs 466.45 |
| 52 Week High | Rs 542 |
| 52 Week Low | Rs 310.2 |
| Market Cap | Rs 4,081 crore |
| Trailing PE | 20x |
| 12-Month Analyst Target | Rs 560 |
| Bull Case Target | Rs 675 |
| Bear Case Target | Rs 375 |
Why Is the TruAlt Bioenergy Share Price Target Set at Rs 560 for 2026
FY27 Earnings Recovery and Revenue Acceleration
The TruAlt Bioenergy share price target of Rs 560 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for re-rating from CMP Rs 466.45.
Structural Sector Tailwinds in Biofuel and Ethanol Production
The Biofuel and Ethanol Production sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. TruAlt Bioenergy’s position among peers in bioenergy like Praj Industries and ISGEC Heavy Engineering creates a structural growth runway, with sustained outperformance being one of the key conditions for the Rs 675 bull case to materialise.
RBI Rate Cut Cycle and Lower Cost of Capital
India’s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve TruAlt Bioenergy’s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 560 analyst consensus.
Union Budget 2026-27 Capex Push and Policy Support
Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable backdrop for TruAlt Bioenergy’s Biofuel and Ethanol Production operations, improving the probability of achieving the Rs 560 price objective through FY27 earnings delivery.
FII Flow Normalisation After the 2026 Tariff Shock
As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 20x PE, TruAlt Bioenergy is positioned as a beneficiary of institutional reallocation toward the Rs 675 bull case over the medium term.
TruAlt Bioenergy Share Price Targets: Short Term, 12 Month, and Long Term
Short Term TruAlt Bioenergy Share Price Target
Near-term support for TruAlt Bioenergy is anchored close to the 52 week low of Rs 310.2. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating from CMP Rs 466.45.
12-Month TruAlt Bioenergy Share Price Target 2026
The 12-month TruAlt Bioenergy share price target 2026 is Rs 560, implying approximately 20 percent upside from CMP Rs 466.45. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows.
Long Term TruAlt Bioenergy Share Price Target: FY27 to FY28
The long term TruAlt Bioenergy share price target for FY27 to FY28 is Rs 675 in the bull case, requiring full earnings delivery, re-rating among peers in bioenergy like Praj Industries and ISGEC Heavy Engineering, and sustained institutional buying over a 2 to 3 year horizon.
Bull Case and Bear Case Scenarios for TruAlt Bioenergy in 2026
Bull Case TruAlt Bioenergy Share Price Target: Rs 675
The bull case TruAlt Bioenergy share price target of Rs 675 materialises when FY27 earnings beat analyst estimates, Biofuel and Ethanol Production tailwinds accelerate, and FII flows return strongly to Indian equities, representing approximately 45 percent potential upside from CMP Rs 466.45.
Bear Case TruAlt Bioenergy Share Price Target: Rs 375
The bear case TruAlt Bioenergy share price target of Rs 375 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of support near the 52 week low of Rs 310.2.
| Scenario | Target | Key Conditions |
|---|---|---|
| Bull Case | Rs 675 | FY27 beat, sector re-rating, FII inflows |
| Base Case (Analyst Target) | Rs 560 | In-line FY27 delivery, partial FII recovery |
| Bear Case | Rs 375 | FY27 miss, guidance cut, FII outflows persist |
Key Risks That Could Derail the TruAlt Bioenergy 2026 Price Objective
Global Macro and US Tariff Headwinds
Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the TruAlt Bioenergy share price target of Rs 560, with FII outflows being the direct transmission mechanism to Indian equity valuations.
FY27 Earnings Miss and Guidance Risk
An FY27 earnings miss or downward guidance revision would compress valuation multiples and is the most direct company-specific risk to the Rs 560 analyst price objective. Investors must monitor quarterly results and management commentary closely.
Competitive Intensity Among Biofuel and Ethanol Production Peers
Intensifying competition from peers in bioenergy like Praj Industries and ISGEC Heavy Engineering could compress TruAlt Bioenergy’s market share and pricing power, a structural risk that must be weighed when assessing the defensibility of the earnings trajectory underpinning the Rs 560 analyst target for 2026.
Liquidity Risk and FII Selling Pressure
Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should maintain position sizing discipline and stop losses to protect capital.
How to Invest in TruAlt Bioenergy
Check the Univest Screener for live data
Before considering any investment based on the TruAlt Bioenergy share price target of Rs 560, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Biofuel and Ethanol Production sector demand.
Open a Demat account with a SEBI registered stockbroker to trade TruAlt Bioenergy (NSE: TRUALT) with full regulatory protection. Study the competitive landscape among peers in bioenergy like Praj Industries and ISGEC Heavy Engineering before executing any position.
Plan your entry using the 52 week low of Rs 310.2 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 560 price objective. Always set a stop loss below the 52 week low.
Restrict any single stock to 3 to 5 percent of your total equity portfolio. Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.
Download the Univest iOS App or the Univest Android App to track TruAlt Bioenergy’s live share price and receive daily stock recommendations.
Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.
FAQs on TruAlt Bioenergy Share Price Target 2026
What is the TruAlt Bioenergy share price target for 2026?
Ans. The TruAlt Bioenergy share price target 2026 is Rs 560, implying approximately 20 percent upside from CMP Rs 466.45. Bull case is Rs 675, bear case is Rs 375.
What was the TruAlt Bioenergy share price target for 2025?
Ans. The 2025 price objective for TruAlt Bioenergy was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 560, reflecting FY27 growth potential from CMP Rs 466.45.
Is TruAlt Bioenergy a good investment at Rs 466.45?
Ans. At Rs 466.45, TruAlt Bioenergy offers potential upside toward Rs 560 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance. Consult a SEBI registered financial advisor before investing.
What are the key risks to the TruAlt Bioenergy share price target 2026?
Ans. Key risks to the TruAlt Bioenergy share price target of Rs 560 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Biofuel and Ethanol Production. Monitoring quarterly results is essential.
What is the 52 week high and low of TruAlt Bioenergy?
Ans. The 52 week high of TruAlt Bioenergy is Rs 542 and the 52 week low is Rs 310.2. At CMP Rs 466.45, the stock offers potential upside toward the Rs 560 price objective.
What are the main growth catalysts for TruAlt Bioenergy in 2026?
Ans. Key catalysts include FY27 PAT recovery, Biofuel and Ethanol Production tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.
How does TruAlt Bioenergy compare to its peers?
Ans. TruAlt Bioenergy operates in Biofuel and Ethanol Production alongside peers in bioenergy like Praj Industries and ISGEC Heavy Engineering. At CMP Rs 466.45 with MCap Rs 4,081 crore, it is a potential re-rating candidate toward the TruAlt Bioenergy share price target of Rs 560 on FY27 delivery.
What is the TruAlt Bioenergy share price target for 2027?
Ans. The long-term TruAlt Bioenergy share price target for FY27 to FY28 is Rs 675 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.
